Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02883335

Lorraine Registry of Multiple Sclerosis

The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy

Nancy, 54000, France

Location status: Recruiting

Location contact

Jonathan Epstein, MD, MSc

CONTACT

[email protected]

About this study

As every patient registry in France, the RelSEP is periodically (every four years) evaluated by an independent committee.

The RelSEP interrogate multiple sources to insure its exhaustiveness :

  • every neurologists of Lorraine
  • MS patient network in Lorraine
  • health insurance data
  • PMSI (administrative French national database for hospitals)
  • biological and imagery services in Lorraine Procedures (automatic and manual) are used to eliminate duplicates Once a patient has been identified its medical file are checked by investigators in order to retrieve the relevant information.

New MS cases are confirmed by neurologists. Automatics (implemented in EDMUS software)and manual checks are implemented in the registry database, looking for inconsistencies.

The following data are registered :

  • Name, birthname
  • Sex
  • Date of birth
  • Location (town)
  • Birth location (town)
  • Profession
  • Number of siblings
  • Marital status
  • Number of children
  • Date of onset
  • Date and nature of clinical manifestations
  • MRI reports
  • CSF analysis reports
  • Event-related potential reports
  • Impairment and disability evolution
  • Treatments (start and change of drug treatment)
  • Drugs related events
  • Cause of treatment discontinuation
  • Disease progression Every case has a follow up at least every two years.

The quality of data is evaluated by periodically auditing cases at random from our database.

An annual report on the main data (incidence and prevalence) of MS in Lorraine is produced.

Data are also used for observational studies on prognostic factors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having a confirmed multiple sclerosis diagnosis
  • Living in Lorraine (French region)

Exclusion criteria

  • Refusal to be registered

Treatment and study plan

OBSERVATIONAL REGISTRY

Other

Primary outcomes

  1. case occurence of multiple sclerosis

    Time frame: one year

Secondary outcomes

  1. EDSS score

    Time frame: 30 years

Study contacts

Contact information is provided by the study sponsor or research team.

Francis Guillemin, MD, PHD

CONTACT

[email protected]

Jonathan Epstein, MD, MSc

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France
  • University of Lorraine

Registry information

Acronym: RelSEP

Important dates

Study start
2003
Primary completion
2030
Study completion
2030
First posted
Aug 30, 2016
Registry last updated
Feb 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.